| Literature DB >> 35655480 |
Hanae Naceiri Mrabti1, Naoual El Menyiy2, Saoulajan Charfi3, Mohammed Saber4, Saad Bakrim5, Reema A Alyamani6, Abdur Rauf7, Ahmed M H Ali8,9, Emad M Abdallah9, Naserddine El Omari10, Abdelhakim Bouyahya11, Hamza Assaggaf12.
Abstract
The family Lamiaceae contains several plants used in traditional medicine to fight against different diseases. Salvia verbenaca L. (S. verbenaca) is one of the Lamiaceae species distributed around the Mediterranean regions. This plant exhibits different bioactive properties, including antibacterial, anticancer, antioxidant, antileishmanial, antidiabetic, immunomodulatory, and wound healing. This review was conducted to revise previous studies on S. verbenaca addressing its botanical description, geographical distribution, and phytochemical, pharmacological, and toxicological properties. Moreover, the main pharmacological actions of S. verbenaca major compounds were well investigated. Literature reports have revealed that S. verbenaca possesses a pivotal role in medicinal applications. The findings of this work noted that S. verbenaca was found to be rich in chemical compound classes such as terpenoids, phenolics, fatty acids, sterols, and flavonoids. Numerous studies have found that S. verbenaca essential oils and extracts have a wide range of biological effects. These results support the potential pharmacological properties of S. verbenaca and its traditional uses. This analysis can constitute a scientific basis for further refined studies on its pure secondary metabolites. Therefore, the outcome of the present work may support the perspective of identifying new therapeutical applications with detailed pharmacological mechanisms of S. verbenaca to prevent the development of some diseases such as neurodegenerative disorders. However, toxicological investigations into S. verbenaca are needed to assess any potential toxicity before it can be further used in clinical studies.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35655480 PMCID: PMC9155978 DOI: 10.1155/2022/3787818
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.246
Figure 1Salvia verbenaca L.: (a) whole plant; (b) aerial part; (c) flowers.
Some medicinal applications of S. verbenaca.
| Part used | Preparation | Traditional application | Ref. |
|---|---|---|---|
| Aerial part | Decoction, infusion | Diabetes | [ |
| Leaf | Decoction, powder | Abdominal colics, cold, fever, healing | [ |
| Leaf | Powder | Wound treatment | [ |
| Leaf | Decoction, infusion | Genitourinary, skin, digestive, and respiratory problems | [ |
| Aerial part | No information | Digestive problems | [ |
| Leaf, whole plant | Powder | Healing of burns, wounds, and abscesses | [ |
NI: no information.
Chemical composition of various parts of S. verbenaca.
| Part used | Country | Harvest site | Harvest season | Extracts/essential oils | Chemical composition | Analysis | References |
|---|---|---|---|---|---|---|---|
| Aerial parts (dry) | Tunisia | Rass Zebib (subhumid) | Flowering period | EO | 1,8-Cineole (9.7%), p-cymene (8.4%), | GC and GC-MS | [ |
| Aerial parts (dry) | Tunisia | Bir Mroua (subhumid) | Flowering period | EO |
| GC and GC-MS | [ |
| Aerial parts (dry) | Tunisia | Beja (higher semiarid) | Flowering period | EO |
| GC and GC-MS | [ |
| Aerial parts (dry) | Tunisia | Tunis (higher semiarid) | Flowering period | EO | Viridiflorol (17.7%), 1,8-cineole (8.5%), | GC and GC-MS | [ |
| Aerial parts (dry) | Tunisia | Touiref (moderate semiarid) | Flowering period | EO |
| GC and GC-MS | [ |
| Aerial parts (dry) | Tunisia | Bou Arada (moderate semiarid) | Flowering period | EO | 1,8-Cineole (9.4%), p-cymene (8.7%), viridiflorol (8.3%), | GC and GC-MS | [ |
| Aerial parts (dry) | Tunisia | Sers (lower semiarid) | Flowering period | EO |
| GC and GC-MS | [ |
| Aerial parts (dry) | Tunisia | Enfidha (lower semiarid) | Flowering period | EO | Viridiflorol (10.5%), camphor (2.9%), epi-13-manool (10.5%), 1,8-cineole (8.7%), p-cymene (8.3%), | GC and GC-MS | [ |
| Aerial parts (dry) | Tunisia | Chott Meriem (higher arid) | Flowering period | EO | p-Cymene (14.2), | GC and GC-MS | [ |
| Aerial parts (dry) | Tunisia | Hencha (higher arid) | Flowering period | EO | Viridiflorol (10.0%), bicyclogermacrene (2.3%), germacrene D (5.6%), 1,8-cineole (4.9), epi-13-manool (4.7%), | GC and GC-MS | [ |
| Aerial parts (dry) | Spain | Murcia | Flowering stage | EO | p-Cymene (11.4%), 1,8-cineole (7.7%), viridiflorol (7.0%), camphene (2.7%), | GC and GC-MS | [ |
| Aerial parts (dry) | Spain | Murcia | Early fruiting stage | EO | Caryophyllene oxide (12.4%), bornyl acetate (3.2%), viridiflorol (9.1%), | GC and GC-MS | [ |
| Aerial parts (dry) | Spain | Murcia | Late fruiting stage | EO |
| GC and GC-MS | [ |
| Aerial parts | Algeria | Bechar | April 2011 | EO | Epi- | GC and GC-MS | [ |
| Aerial parts (fresh) | Jordan | Shafa-Badran-Amman | Flowering period (April to May 2011) | EO | Linalool (61.32%), | GC-MS and GC-FID | [ |
| Aerial parts (dry) | Jordan | Shafa-Badran-Amman | Flowering period (April to May 2011) | EO | Linalool (30.72%), bicyclogermacrene (14.70%), | GC and GC-MS | [ |
| Stem | Jordan | Mediterranean | Full maturation period | EO |
| GC-MS and GC-FID | [ |
| Jordan | Irano-Turanian | Full maturation period | EO |
| GC and GC-MS | [ | |
| Leaves | Jordan | Mediterranean | Full maturation period | EO |
| GC and GC-MS | [ |
| Leaves | Jordan | Irano-Turanian | Full maturation period | EO |
| GC and GC-MS | [ |
| Preflower | Jordan | Mediterranean | Full maturation period | EO |
| GC and GC-MS | [ |
| Preflower | Jordan | Irano-Turanian | Full maturation period | EO | Sabinene (42.7%), | GC and GC-MS | [ |
| Flower | Jordan | Mediterranean | Full maturation period | EO |
| GC and GC-MS | [ |
| Jordan | Irano-Turanian | Full maturation period | EO | Sabinene (37.5%), | GC and GC-MS | [ | |
| Petal | Jordan | Mediterranean | Full maturation period | EO |
| GC and GC-MS | [ |
| Petal | Jordan | Irano-Turanian | Full maturation period | EO |
| GC and GC-MS | [ |
| Sepal | Jordan | Mediterranean | Full maturation period | EO |
| GC and GC-MS | [ |
| Sepal | Jordan | Irano-Turanian | Full maturation period | EO |
| GC and GC-MS | [ |
| Aerial parts | Algeria | Mogheul | April 2011 | EO | Germacrene D (20.5%), | GC and GC-MS | [ |
| Seeds | Spain | — | — | EO | Camphor (38.94%), 13- | GC-MS and GC-FID | [ |
| Aerial parts | Greece | Crete Island | Blossoming (April 2004) | EO | Beta-phellandrene (30.3%), methyl ester of 6-octadecenoic acid (15.0%), camphor (7.0%), ( | GC and GC-MS | [ |
| Aerial parts (fresh) | Sicily | Piano Battaglia | Full flowering stage (July 2009) | EO | Hexadecanoic acid (23.1%), ethyl hexadecanoate (2.6%), benzaldehyde (7.3%), 9,12,15-octadecatrienal (2.9%), limonene (2.0%), ( | GC and GC-MS | [ |
| Aerial parts | Algeria | Djelfa | March 2019 | EO |
| GC and GC-MS | [ |
| Leaves and flowers (dried) | Turkey | Kütahya-Gediz | 2016-2017 | EO | Linalyl acetate (81.97%), | GC and GC-MS | [ |
| Aerial parts (wild) | Sicily | Piano Battaglia | Full flowering stage (July 2009) | EO | Hexadecanoic acid (23.1%), benzaldehyde (7.3%), b-phellandrene (5.9%), limonene (2.0%), 9,12,15-octadecatrienal (2.9%), ethyl hexadecanoate (2.6%), caryophyllene oxide (1.9%), ( | GC and GC-MS | [ |
| Aerial parts (cultivated) | Sicily | Piano Battaglia | July 2010 | EO | Hexadecanoic acid (11.0%), ( | GC and GC-SM | [ |
| Fruits | Tunisia | Sabelet Ben Ammar | Full fruit ripening stage | EO |
| GC and GC-MS | [ |
| Stems | Tunisia | Sabelet Ben Ammar | Full fruit ripening stage | Camphor (10.9%), terpinolene (6.6%), methyl eugenol (6.1%), | GC and GC-MS | [ | |
| Leaves | Tunisia | Sabelet Ben Ammar | Full fruit ripening stage | epi-13-Manool (13.7%), camphor (3.9%), caryophyllene oxide (3.9%), | GC and GC-MS | [ | |
| Aerial parts | Tunisia | Sabelet Ben Ammar | Full fruiting stage (April 2007) | EO | Viridiflorol (21.6%), methyl eugenol (9.4%), | GC and GC-MS | [ |
| Aerial parts | Tunisia | Sers | Full fruiting stage (April 2007) | ( | GC and GC-MS | [ | |
| Aerial parts | Tunisia | Somaa | Tricyclene (18.8%), nonane (10.3%), terpinolene (7.3%), -terpineol (2.2%), bornyl acetate (4.9%), camphor (2.9%), | GC and GC-MS | [ | ||
| Seeds | Tunisia | Sabelet Ben Ammar | Full ripeness (April 2007) | EO | Camphor (33.83%), caryophyllene oxide (10.11%), octane (4.78%), 13-epi-manool (3.57%), hexanal (2.46%), | GC-MS and GC-FID | [ |
| Seeds | Tunisia | Sabelet Ben Ammar | Full ripeness (April 2007) | Lipid extraction | Palmitic acid (9.25%), stearic acid (2.48%), linolenic acid (45.89%), arachidic acid (0.20%), C18:3n-3/C18:2n-6 (1.67%), SFA (11.93%), USFA (88.07%), oleic acid (14.67%), linoleic acid (27.39%), palmitoleic acid (0.12%) | GC and GC-MS | [ |
| Seeds | Tunisia | Sers | Full ripeness (April 2007) | EO |
| GC and GC-MS | [ |
| Seeds | Tunisia | Sers | Full ripeness (April 2007) | Lipid extraction | Palmitic acid (9.63%), oleic acid (14.14%), linoleic acid (23.79%), linolenic acid (42.84%), SFA (18.35%), USFA (81.65%), stearic acid (4.22%), arachidic acid (4.50%), C18:3n-3/C18:2n-6 (1.53%), palmitoleic acid (0.89%) | GC and GC-MS | [ |
| Seeds | Tunisia | Somaa | Full ripeness (April 2007) | EO | Octane (27.39%), | GC and GC-MS | [ |
| Seeds | Tunisia | Somaa | Full ripeness (April 2007) | Lipid extraction | Palmitic acid (12.11%), stearic acid (3.02%), linoleic acid (25.33%), arachidic acid (1.30%), SFA (16.43%), linolenic acid (41.71%), oleic acid (15.51%), USFA (83.57%), C18:3n-3/C18:2n-6 (1.65%), palmitoleic acid (1.02%) | GC and GC-MS | [ |
| Aerial part | Algeria | Bordj Bou Arreridj | Flowering stage (spring April-May) | Crude extract (CrE) | Flavonoids (08.40 ± 0.32 mg EQ/g E), polyphenols (177.56 ± 2.51 mg EGA/g E) | Spectrophotometrically | [ |
| Aerial part | Algeria | Bordj Bou Arreridj | Chloroform extract (ChE) | Flavonoids (14.87 ± 0.81 mg EQ/g E), polyphenols (156.81 ± 1.57 mg EGA/g E) | Spectrophotometrically | [ | |
| Aerial part | Algeria | Bordj Bou Arreridj | Ethyl acetate extract (EAE) | Flavonoids (28.81 ± 0.38 mg EQ/g E), polyphenols (661.78 ± 4.00 mg EGA/g E) | Spectrophotometrically | [ | |
| Aerial part | Algeria | Bordj Bou Arreridj | Aqueous extract (AqE) | Flavonoids (06.74 ± 0.14 mg EQ/g E), polyphenols (123.18 ± 4.20 mg EGA/g E) | Spectrophotometrically | [ | |
| Aerial part | Algeria | Laghouat | May 2004 | 80% ( | Flavonoids (3.04 ± 0.01 mg RE/g dw), total phenols (7.2 ± 0.04 mg GAE/g dw), flavonols (0.85 ± 0.001 mg QE/g dw) | Spectrophotometrically | [ |
| Aerial part | Algeria | Setif and Batna | 2016 | Decoction | Total phenols (129.02 ± 2.67 mg GAE/g DW), total flavonoid contents (18.62 ± 0.06 mg QE/g DW), total tannin contents (73.80 ± 2.23 mg TAE/g DW) | Spectrophotometrically | [ |
| Aerial part | Algeria | Setif and Batna | 2016 | Methanol extract (85%) | Total phenols (190.16 ± 1.74 mg GAE/g DW) | Spectrophotometrically | [ |
| Aerial part | Turkey | Artvin | 06th September 2004 | Methanol extracts | Rosmarinic acids (29.30 ± 0.24 | Spectrophotometrically | [ |
| Rosmarinic acids (26.12 ± 0.73 | HPLC | [ | |||||
| Aerial parts | Tunisia | Tunis (higher semiarid) | Flowering stage (March and April 2008) | Methanolic extracts |
| HPLC-UV | [ |
| Aerial parts | Tunisia | Bir Mroua (subhumid) | Flowering stage (March and April 2008) | Methanolic extracts |
| HPLC-UV | [ |
| Aerial parts | Tunisia | Hencha (higher arid) | Flowering stage (March and April 2008) | Methanolic extracts |
| HPLC | [ |
| Aerial parts (dried) | Saudi Arabia | Assir | 18th February 2001 | Alcoholic extract | Verbenacines and salvinines | 1D and 2D NMR | [ |
| Roots (dried) | Algeria | Batna | — | Acetone extract | 6,7-Dehydroroyleanones, cryptanol, sitosterols, campesterols, 6-hydroxysalvonolones, microstegiols, stigmasterols | IR, UV, 1H 13C NMR, and NMR | [ |
Figure 2Terpenoid structures identified from S. verbenaca EO.
Figure 3Phenolic acids and phenolic diterpenes isolated from S. verbenaca.
Figure 4Flavonoids of S. verbenaca extracts.
Figure 5Some fatty acids isolated from S. verbenaca extracts.
Figure 6Structure of compounds isolated from S. verbenaca.
Figure 7Pharmacological properties of S. verbenaca.
Antibacterial potential of S. verbenaca extracts and EOs.
| Plant section | Extracts | Methodology | Tested bacterial strains | Antibacterial results | Ref. |
|---|---|---|---|---|---|
| Aerial parts | Ethanolic extract | Disc diffusion method dose (20 | Gram positive |
| [ |
| Not specified | Methanolic extract (80%) | Not specified | Not specified | The 80% methanol extract prepared using ultrasound extraction showed the highest antimicrobial activity | [ |
| Aerial parts | Methanolic extract | Minimum inhibitory concentration | Gram positive | MIC = 500 | [ |
|
| MIC = 700 | ||||
| Aerial parts | Methanol : chloroform (1 : 1, | Microdilution assay | Gram positive | MIC = 2.0 mg/mL | [ |
| Aerial parts | Methanolic extract subfractions: | Disc diffusion method | Gram positive | EAE | [ |
|
| EAE | ||||
|
| EAE | ||||
|
| EAE | ||||
| Gram negative | EAE | ||||
|
| EAE | ||||
|
| EAE | ||||
|
| EAE | ||||
|
| EAE | ||||
|
| No inhibition | ||||
| Leaves | Ethyl acetate extract | Agar diffusion test | Gram positive | MIC = 50 | [ |
| Aerial parts | Essential oil | Broth dilution method | Gram positive | MIC = 50 | [ |
| Gram negative | MIC > 100 |
Ф: diameter of inhibition.
Antioxidant activity of S. verbenaca.
| Part used | Extracts | Methods used | Key results | Ref. |
|---|---|---|---|---|
| Not specified | Methanolic extract (80%) | DPPH assay | The 80% methanol extract prepared by maceration was highly active | [ |
| Aerial parts (stems and leaves) | Hydromethanolic extract | Oxygen consumption | A strong inhibition of oxygen consumption (92%) | [ |
| Conjugated diene formation (CD) | A strong inhibition of CD formation of LDL peroxidation (92%) | |||
| Thiobarbituric acid reactive substance (TBARS) formation | A strong inhibition of TBARS formation of linolenic acid oxidation (93%) | |||
| Not specified | Methanolic extract | DPPH assay | IC50 = 14.30 ± 1.42 | [ |
| Aerial parts | Methanolic extract | DPPH assay | IC50 = 86.9 | [ |
| ABTS assay | IC50 at 5 min = 777.3 | |||
| Aerial parts | Methanolic extract from postdistilled plant | DPPH method | Sers: IC50 = 24.47 ± 1.87 | [ |
| ABTS method | Hencha: TEAC = 120.11 ± 6.62 | |||
| FRAP | Beja: 142.07 ± 1.46 mM Fe+2/mg | |||
| Aerial parts | Crude extract | DPPH method | IC50 = 47.50 | [ |
| Aerial parts | Methanolic extract | DPPH | IC50 = 9.79 ± 0.47 | [ |
| Not specified | Methanolic extract | DPPH method | IC50 = 16.92 ± 0.2 | [ |
| Aerial parts | Methanolic extract subfractions: | DPPH method | EAE: IC50 = 0.0086 mg/mL | [ |
| Reducing power method | EAE: EC50: 0.0047 mg/mL | |||
| Metal chelating method | AqE and CrE reported the highest activity | |||
| Aerial parts | Methanolic extracts (85%) (ME) | DPPH method | ME: IC50: 24.36 ± 1.13 | [ |
| ABTS method | ME: IC50: 19.96 ± 1.03 | |||
| Alkaline DMSO superoxide radical scavenging | ME: IC50: 07.77 ± 1.00 | |||
|
| DE: inhibition: 96.12 ± 2.48% | |||
| Reducing power method | DE: EC50: 69.52 ± 3.07 | |||
| Metal chelating activity method | ME: IC50: 70.39 ± 1.13 | |||
| Phenanthroline method | ME: IC50: 27.03 ± 1.54 | |||
| Cupric reducing antioxidant capacity (CUPRAC) | ME: A0.50: 14.66 ± 2.51 | |||
| Root | Methanolic extract | H2DCF-DA method | Significant reduction in the intracellular reactive oxygen species (ROS) level for both tested values (1 and 10 | [ |
Anticancer effects of S. verbenaca.
| Plant part | Tested extract | Cell lines | Major results | Ref. |
|---|---|---|---|---|
| Leaves | Ethyl acetate | Human breast adenocarcinoma | IC50: 41.3 ± 4.8 | [ |
| Aerial parts | Methanol | Human colon adenocarcinoma | LC50: 60.4 | [ |
| Human hepatoblastoma | LC50: 68.9 | |||
| Human breast cancer cells | LC50: 43.1 | |||
| Human pancreatic carcinoma | LC50: 42.2 | |||
| Aerial parts | Hexane | Human embryonal rhabdomyosarcoma cancerous cell lines | IC50: 474.6 ± 1.3 | [ |
| Vero (monkey kidney cancerous cell lines) | IC50 > 500 | |||
| Aerial parts | Ethyl acetate | Human embryonal rhabdomyosarcoma cancerous cell lines | IC50 > 500 | [ |
| Vero (monkey kidney cancerous cell lines) | IC50: 223.6 ± 1.6 | |||
| Aerial parts |
| Human embryonal rhabdomyosarcoma cancerous cell lines | IC50 > 500 | [ |
| Vero (monkey kidney cancerous cell lines) | IC50 > 500 | |||
| Aerial parts | Methanol and chloroform | Breast adenocarcinoma | IC50: 31.5 ± 13.7 | [ |
| Colon adenocarcinoma | IC50: 50.0 ± 5.3 | |||
| Glioblastoma | IC50 was not calculated | |||
| Human kidney epithelial cell line | IC50: 20.8 ± 2.5 | |||
| Leaves | Methanol | Monkey kidney cells | CC50: 64 | [ |
| Human larynx cancer cells | CC50 = 64 | |||
| Roots | Methanol | Human monocytic leukemia cell line | 70% of apoptosis and 30% of viable cells at a 1000 | [ |
| Aerial parts | Essential oils | Human melanoma cell line | IC50 = 8.1 ± 0.6 | [ |
Antiparasitic activity of S. verbenaca.
| Activity | Part used | Extract | Parasite | Major results | Ref. |
|---|---|---|---|---|---|
| Antileishmanial activity | Whole plant part |
|
| IC50: 155.4 | [ |
|
| IC50: 148.2 | ||||
|
| IC50: 14.1 | ||||
| Dichloromethane |
| IC50: 24.5 | |||
|
| IC50: 33.7 | ||||
|
| IC50: 31.5 | ||||
| Methanol |
| IC50 > 1000 | |||
|
| IC50: 850.7 | ||||
|
| IC50 > 1000 | ||||
| Antimalarial activity | Aerial parts | Methanol chloroform |
| IC50: 23.9 ± 1.1 | [ |
Other biological activities of S. verbenaca.
| Activity | Part used | Extracts | Experiment | Major results | Ref. |
|---|---|---|---|---|---|
| Antihemolytic | Aerial part | Ethyl acetate | 2,2-Azobis (2-amidinopropane) dihydrochloride induces erythrocyte oxidative hemolysis (AAPH) | HT50: 165 min | [ |
| Crude | HT50: 125.1 min | ||||
| Chloroform | HT50: 111.5 min | ||||
| Aqueous | HT50: 111.5 min | ||||
| Xanthine oxidase inhibition | Aerial part | Chloroform | Colorimetric approach based on uric acid generation at 295 nm in the presence of 100 mM xanthine in phosphate buffer | IC50: 0.0088 ± 0.0 mg/mL | |
| Ethyl acetate | IC50: 0.0165 ± 0.001 mg/mL | ||||
| Crude | IC50: 0.0520 ± 0.003 mg/mL | ||||
| Aqueous | IC50: 0.9800 ± 0.004 mg/mL | ||||
| Porcine liver carboxylesterase inhibition | Aerial part | Aqueous methanol | Enzyme inhibition by spectrophotometric assay | CE (carboxylesterase) inactivation with a pI = 5.1 and a Ki value of 38 Mm | [ |
| Healing of burns | Leaves | Hexane | Second-degree burn injury induced by a hot metal cylinder in rats | Accelerated healing process with 44.34% | [ |
| Ethyl acetate | Accelerated healing process with 47.55% | ||||
|
| Accelerated healing process with 49.16% | ||||
| Anticholinesterases | Aerial part | Methanol | Cholinesterase inhibition | Inhibition effect of AChE at 100 | [ |
| Anti- |
| IC50: 01.3 ± 0.08 | |||
| Anti- |
| IC50 = 150.5 ± 1.4 | |||
| Immunomodulatory | Aerial parts | Methanol | Phagocytic activity used carbon clearance rate test | Significantly increased phagocytic index (0.095 ± 0.012) at a dose of 200 mg/kg | [ |
Figure 8Antidiabetic mechanism insights of S. verbenaca main compounds.
Toxicological studies of S. verbenaca.
| Activities | Part used | Extract | Experimental approach | Major results | Ref. |
|---|---|---|---|---|---|
| Acute oral toxicity | Aerial parts |
| Orally delivered at a dose of 2000 mg/kg in a volume of 0.25 mL per 20 g of body weight to mice and examined for 14 days | LD50 > 2000 mg/kg body weight | [ |
| Acute dermal toxicity | Aerial parts | Hexane, ethyl acetate, | For 14 days, daily topical application of | There are no adverse effects, behavioral problems, or fatalities | [ |
| Subchronic dermal toxicity | Aerial parts | Hexane, ethyl acetate, | For 28 days, daily topical application of | There are no harmful symptoms or changes in the amount of water or food consumed | [ |
Figure 9Suggested antibacterial mechanisms of S. verbenaca compounds.